Skip to content

Nuvation Bio NUVB Warrant Liability

Warrant Liability at other companies

Archer Aviation logo
Archer AviationACHR
$7.1M-85.1%
uniQure logo
uniQureQURE
$8.61M
Cipher Digital, Inc.
 logo
Cipher Digital, Inc. CIFR
$481.55M
Butterfly Network logo
Butterfly NetworkBFLY
$0-100%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$34.33M+4,477%
TeraWulf logo
TeraWulfWULF
$1.06B

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept nuvb:WarrantLiability.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's warrant liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's warrant liability?
Nuvation Bio (NUVB) reported warrant liability of $0 in Q1 2026.
How has Nuvation Bio's warrant liability changed year-over-year?
Nuvation Bio's warrant liability decreased by 100.0% year-over-year, from $2.8M to $0.
What does warrant liability mean?
This represents the total fair value of all outstanding warrants classified as liabilities on the balance sheet, regardless of maturity. It reflects the company's long-term exposure to equity-linked financial instruments that must be settled in cash or shares. Tracking this helps investors understand the potential dilution or cash settlement risk associated with the company's capital structure.